$36.26+0.84 (+2.37%)
Transcontinental Realty Investors, Inc., a Dallas-based real estate investment company, holds a diverse portfolio of equity real estate located across the U.S., including office buildings, apartments, shopping centers, and developed and undeveloped land.
Transcontinental Realty Investors, Inc. in the Real Estate sector is trading at $36.26. The stock is currently 39% below its 52-week high of $59.65, remaining 19.5% below its 200-day moving average. Technical signals show neutral RSI of 33 and bearish MACD signal, explaining why TCI maintains its current current market pressure. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Transcontinental Realty Investors, Inc., a Dallas-based real estate investment company, holds a diverse portfolio of equity real estate located across the U.S., including office buildings, apartments, shopping centers, and developed and undeveloped l...
Over the last 7 days, the United States market has remained flat, yet it has experienced a significant rise of 28% over the past year with earnings projected to grow by 16% annually. In this dynamic environment, identifying stocks that are under-the-radar yet poised for growth can offer unique opportunities for investors.
AMREP and Transcontinental Realty face different models, footprints and valuations, but which real estate stock looks better positioned right now? Let's dive in.
The Dallas-based company said it had profit of 97 cents per share. Losses, adjusted for asset impairment gains, came to 13 cents per share. The real estate investor posted revenue of $12.1 million in the period.
As the U.S. market grapples with geopolitical tensions and fluctuating bond yields, small-cap stocks in the S&P 600 have shown resilience amid broader market volatility. With major indices like the Dow Jones and Nasdaq experiencing declines due to tariff threats, investors are increasingly turning their attention to lesser-known opportunities that may offer growth potential in uncertain times. In this context, identifying a good stock often involves looking for companies with strong...
Alumis, Aktis Oncology, and W.R. Berkley saw the most prominent insider buying of the past week. There were a handful of other notable purchases as well.